PH31320A - Fenbendazole formulations. - Google Patents

Fenbendazole formulations.

Info

Publication number
PH31320A
PH31320A PH49328A PH49328A PH31320A PH 31320 A PH31320 A PH 31320A PH 49328 A PH49328 A PH 49328A PH 49328 A PH49328 A PH 49328A PH 31320 A PH31320 A PH 31320A
Authority
PH
Philippines
Prior art keywords
fenbendazole
formulations
standing
efficacious
agglomerate
Prior art date
Application number
PH49328A
Other languages
English (en)
Inventor
Leslie E Kyle
Original Assignee
Hoechst Roussel Agri Vet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Agri Vet Co filed Critical Hoechst Roussel Agri Vet Co
Publication of PH31320A publication Critical patent/PH31320A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
PH49328A 1993-11-10 1994-11-08 Fenbendazole formulations. PH31320A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/149,877 US5538989A (en) 1993-11-10 1993-11-10 Fenbendazole formulations

Publications (1)

Publication Number Publication Date
PH31320A true PH31320A (en) 1998-07-06

Family

ID=22532170

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49328A PH31320A (en) 1993-11-10 1994-11-08 Fenbendazole formulations.

Country Status (14)

Country Link
US (1) US5538989A (fr)
EP (1) EP0727996B1 (fr)
JP (1) JP3523260B2 (fr)
KR (1) KR960705563A (fr)
AT (1) ATE221780T1 (fr)
BR (1) BR9408023A (fr)
CA (1) CA2176223C (fr)
DE (1) DE69431162T2 (fr)
DK (1) DK0727996T3 (fr)
ES (1) ES2181763T3 (fr)
MY (1) MY115429A (fr)
PH (1) PH31320A (fr)
PT (1) PT727996E (fr)
WO (1) WO1995013065A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES950907A2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd "A process"
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
MXPA02002360A (es) * 1999-09-03 2002-07-30 Janssen Pharmaceutica Nv Formulacion veterinaria para administracion de un farmaco insoluble en agua a un animal objetivo mediante un sistema de distribucion de agua.
GB0105358D0 (en) * 2001-03-03 2001-04-18 Fluid Technologies Ltd Absorbent materials
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (fr) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Formulations anthelmintiques a actions multiples
BRPI0509673A (pt) * 2004-04-07 2007-10-09 Intervet Int Bv composição para o tratamento de parasitas, forma de dosagem farmacêutica, método para tratar um organismo, e, processos para introduzir pelo menos um aditivo em um organismo, para fabricar uma composição, para liberar um aditivo em um organismo, e, para conformar um produto macio mastigável
KR101403135B1 (ko) * 2006-06-14 2014-06-19 인터벳 인터내셔널 비.브이. 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물
EP2409683A1 (fr) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Formulations aqueuses stables comprenant des ingrédients actifs faiblement solubles dans l'eau
JP5575269B2 (ja) * 2010-08-24 2014-08-20 大塚製薬株式会社 カルボスチリル誘導体並びにシリコーンオイル及び/又はシリコーンオイル誘導体を含有する懸濁液及びケーキ組成物
CA3033065A1 (fr) * 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Compositions de medicaments.
CN106727304B (zh) * 2017-04-06 2019-09-03 江西博莱大药厂有限公司 一种芬苯达唑混悬剂及其制备方法
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2024026463A1 (fr) * 2022-07-28 2024-02-01 Happy Healing Inc. Composition pour l'administration nasale d'un composé actif
CN116602964B (zh) * 2023-07-18 2023-09-22 山东国邦药业有限公司 一种芬苯达唑粉及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE684059A (fr) * 1965-07-15 1967-01-13
BE793358A (fr) * 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
US3897559A (en) * 1972-07-06 1975-07-29 Lilly Co Eli Anthelmintic phenylhydrazones
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US4197307A (en) * 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
ATE29217T1 (de) * 1982-03-30 1987-09-15 Hoechst Uk Ltd Anthelmintika.

Also Published As

Publication number Publication date
PT727996E (pt) 2002-11-29
CA2176223A1 (fr) 1995-05-18
US5538989A (en) 1996-07-23
BR9408023A (pt) 1996-12-10
MY115429A (en) 2003-06-30
WO1995013065A1 (fr) 1995-05-18
JPH09506086A (ja) 1997-06-17
ATE221780T1 (de) 2002-08-15
JP3523260B2 (ja) 2004-04-26
EP0727996B1 (fr) 2002-08-07
EP0727996A1 (fr) 1996-08-28
DK0727996T3 (da) 2002-11-18
KR960705563A (ko) 1996-11-08
DE69431162D1 (en) 2002-09-12
ES2181763T3 (es) 2003-03-01
CA2176223C (fr) 2003-02-11
DE69431162T2 (de) 2002-12-12
EP0727996A4 (fr) 1996-11-06

Similar Documents

Publication Publication Date Title
AU697584B2 (en) Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
MY115429A (en) Fenbendazole formulations
NZ512792A (en) Stable liquid interferon beta formulations
AU4718496A (en) Use of aerogels in agriculture
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
SI0725779T1 (fr)
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
UA42795C2 (uk) Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання
IL115046A (en) Sprayable film-forming preparation for application to plants and the uses thereof
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
AU5652796A (en) Solid compositions containing polyethyleneoxide and a non-am orphous active principle
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
CA2157836A1 (fr) L-carnitine, sel pour compositions cosmetiques et pharmaceutiques permettant de traiter les dermatoses
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
BG101379A (en) New pypimido [1,2-a] indoles
AU5254290A (en) Substituted 1,8-naphthyridines
MD970269A (en) Clavulanates
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
AU7841387A (en) 4-substituted-2,6-diphenylpyridine derivatives, production of the same, and herbicide containing the same as an active ingredient
PL314799A1 (en) Application of dimeticone in treating constipations